Milestone Pharmaceuticals, Inc.
(NASDAQ : MIST)

( )
MIST PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -1.66%128.960.7%$2059.74m
PFEPfizer Inc. -2.79%31.730.9%$1364.19m
MRKMerck & Co., Inc. -3.90%73.940.7%$1266.51m
ABBVAbbVie, Inc. -3.56%73.482.3%$1224.27m
BMYBristol-Myers Squibb Co. -1.58%54.861.0%$1084.03m
LLYEli Lilly & Co. -1.58%136.531.1%$889.90m
NVSNovartis AG -1.80%80.970.2%$302.49m
AZNAstraZeneca Plc -1.97%43.781.2%$287.74m
GSKGlaxoSmithKline Plc -1.77%37.220.2%$260.79m
FTSVForty Seven, Inc. 0.02%95.440.0%$220.30m
NVONovo Nordisk A/S -0.85%59.690.1%$176.02m
SNYSanofi -1.85%42.910.2%$156.51m
BHCBausch Health Cos., Inc. -11.32%13.750.0%$92.75m
RARXRa Pharmaceuticals, Inc. -0.03%48.000.8%$83.59m
RGENRepligen Corp. -2.29%94.337.1%$72.06m

Company Profile

Milestone Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development and commercialization of novel small molecule therapeutics based on clinically-validated mechanisms for the treatment of cardiovascular diseases. The firm designs and develops a rapid-onset nasal spray with Etripamil. The company was founded by Philippe Douville and Philippe Lamarre in 2005 and is headquartered in Montreal, Canada.